Senior Biopharma Reporter (Hybrid/Remote)

Informagroupplc; Washington (District of Columbia); On-site; USD 90,000 - 120,000; Full time

Benefits offered by this job

Great community

Walk the World charity day

Job summary

PharmaVoice is seeking a dynamic Senior Reporter to deliver timely, insightful coverage of the biopharma and biotech industries from our Washington, DC office. You will own your beat, craft enterprise stories, and produce quick-turn news pieces analyzing trends, challenges, and opportunities shaping pharma.

You will lead reporting, edit rigorously, and collaborate with editors to shape high-impact coverage of drug developments, leadership changes, and policy shifts affecting the sector.

Qualifications

• 5+ years of journalism experience, with at least 3 years dedicated to pharma or life sciences.
• Bachelor's degree or higher in Journalism, English, or a related field.
• Proven expertise in reporting on the business of pharmaceuticals.

Responsibilities

• Deliver enterprise reporting, in-depth features, and quick-turn news coverage of biopharma and biotech.
• Cultivate relationships with industry stakeholders and experts for timely insights.
• Attend events, conduct interviews, and translate complex data into compelling stories.
• Collaborate with editors to brainstorm, plan, and execute major editorial projects.
• Edit daily copy to ensure clarity, accuracy, and alignment with editorial standards.

Skills

Industry Knowledge

Analytical Skills

Beat Ownership

Deadline-Driven

Editorial Skills

Education

Bachelor's degree or higher in Journalism, English, or related field

Job description

PharmaVoice is seeking a dynamic Senior Reporter to deliver timely, insightful coverage of the biopharma and biotech industries from our Washington, DC office. You will own your beat, craft enterprise stories, and produce quick-turn news pieces analyzing trends, challenges, and opportunities shaping pharma.

You will lead reporting, edit rigorously, and collaborate with editors to shape high-impact coverage of drug developments, leadership changes, and policy shifts affecting the sector.